Nelarabine activity in acute biphenotypic leukemia.

Nelarabine activity in acute biphenotypic leukemia. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Nelarabine activity in acute biphenotypic leukemia. Abstract Text:

Yesid Alvarado,Mary Alma Welch,Ronan Swords,John Bruzzi,Ellen Schlette,Francis J Giles,Yesid Alvarado,Mary Alma Welch,Ronan Swords,John Bruzzi,Ellen Schlette,Francis J Giles,Yesid Alvarado,Mary Alma Welch,Ronan Swords,John Bruzzi,Ellen Schlette,Francis J Giles,

Nelarabine activity in acute biphenotypic leukemia. Publishing Authors By Initials

Y Alvarado,MA Welch,R Swords,J Bruzzi,E Schlette,FJ Giles,Y Alvarado,MA Welch,R Swords,J Bruzzi,E Schlette,FJ Giles,Y Alvarado,MA Welch,R Swords,J Bruzzi,E Schlette,FJ Giles,

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Nelarabine activity in acute biphenotypic leukemia. Journal Published:

PUBLICATION TYPE: Letter

Journal: Leukemia research

VOLUME: 31

Page Numbers: 1600-3

Journal Abbreviation: Leuk. Res.

ISSN: 0145-2126

DAY: 18

MONTH: 05

YEAR: 2007

Nelarabine activity in acute biphenotypic leukemia. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 7706787

Nelarabine activity in acute biphenotypic leukemia. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: Nelarabine activity in acute biphenotypic leukemia. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Nelarabine activity in acute biphenotypic leukemia.

AFFILIATION: Departments of Leukemia, Radiology, and Hematopathology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.

Country: England

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Leuk Res

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Nelarabine activity in acute biphenotypic leukemia Related Publications

• A perspective on telmisartan and cardiovascular risk.
• Adverse childhood experiences and childhood autobiographical memory disturbance.
• Adverse childhood experiences and prescribed psychotropic medications in adults.
• Allele-specific regulation of primary cilia function by the von Hippel-Lindau tumor suppressor.
• Assessing adaptive behaviour in the post-acute setting following traumatic brain injury: initial reliability and validity of the Adaptive Behaviour and Community Competency Scale (ABCCS).
• Bayesian inference for stochastic epidemic models with time-inhomogeneous removal rates.
• Blood pressure-the better biomarker: delay in clinical application.
• Brain stem gliomas: Patterns of Care in Victoria from 1998-2000.
• Cloretazine for the treatment of acute myeloid leukemia.
• Computational capabilities of recurrent NARX neural networks.
• Expression and regulation of anti-mullerian hormone in an oviparous species, the hen.
• Financial implications of plans to combat methicillin-resistant Staphylococcus aureus (MRSA) in an orthopaedic department.
• Hormone therapy and breast cancer: what factors modify the association?
• Institution of universal screening for Group B streptococcus (GBS) from a risk management protocol results in reduction of early-onset GBS disease in a tertiary obstetric unit.
• Is cancer risk associated with anger control and negative affect? Findings from a prospective cohort study.
• Learning long-term dependencies in NARX recurrent neural networks.
• Nelarabine activity in acute biphenotypic leukemia.
• Nicotine in blood in relation to smoking.
• Occupational exposure to ionizing and non-ionizing radiation and risk of glioma.
• On the distribution of performance from multiple neural-network trials.
• Phase I/II study of the mammalian target of rapamycin inhibitor everolimus (RAD001) in patients with relapsed or refractory hematologic malignancies.
• RECENT CASES OF DENTAL MALPRACTICE.
• Recurrent ectopic pregnancy.
• The cardiometabolic syndrome and calcium channel blocker combination drugs.
• The enduring effects of abuse and related adverse experiences in childhood : A convergence of evidence from neurobiology and epidemiology.
• The management of primary cutaneous melanoma in Victoria in 1996 and 2000.
• The oxygen effect on radiation-induced chromosome aberrations: breakage-versus-recombination hypotheses.
• The rs743572 common variant in the promoter of CYP17A1 is not associated with prostate cancer risk or circulating hormonal levels.
• The von Hippel-Lindau tumour suppressor interacts with microtubules through kinesin-2.
• Treatment of acute lymphoblastic leukaemia : a new era.